GLAXF News and Press, GlaxoSmithKline Plc From 10/28/20

GlaxoSmithKline PLC (GSK) Q3 2020 Earnings Conference Call October 28, 2020 10:00 AM ET Company Participants Sarah Elton-Farr - Head of Investor Relations Emma Walmsley - Chief Executive Officer Iain Mackay - Chief Financial Officer Luke Miels - President, Global Pharmaceuticals David Redfern...

The following slide deck was published by GlaxoSmithKline plc in conjunction with their 2020 Q3 earnings call. For further details see: GlaxoSmithKline plc 2020 Q3 - Results - Earnings Call Presentation

This article is part of a series that provides an ongoing analysis of the changes made to Ariel Investments’ 13F stock portfolio on a quarterly basis. It is based on Ariel Investments’ regulatory 13F Form filed on 08/14/2020. John Rogers’ 13F portfolio value increased ~1...

Source: abc news Vaccines take time to develop because they need to be very safe and also effective. It comes as no surprise (especially for coronavirus vaccine development) that the path to development will involve some findings that need careful consideration. Hence news that the AstraZe...

One of my investments is in a small COVID vaccine company, Heat Biologics ( HTBX ), and I generally route for the little guy. So I don't particularly like writing an article that has a number of facts and reasons why probably none of the remaining small players are going to become major player...

GlaxoSmithKline plc ( GSK ), with a market cap of $103 billion, is recognized as the world's largest vaccine manufacturer and is currently working on several COVID-19 vaccines. While this area of the business has commanded most of the headlines, GSK has a broader immunology portfolio and tre...

This article is part of a series that provides an ongoing analysis of the changes made to Tweedy Browne’s 13F portfolio on a quarterly basis. It is based on Tweedy Browne’s regulatory 13F Form filed on 08/11/2020. Please visit our Tracking Tweedy Browne Portfolio series to ge...

Foreword This article is based on five Kiplinger investing articles, plus one from Barron's Weekly, aimed at survival qualities endemic to our times: Pros' Picks: The 15 Best Nasdaq Stocks , by Dan Burrows, published 5/13/20, "screened the Nasdaq Composite for stocks followed by a m...

Quick Take CureVac ( CVAC ) intends to raise $200 million from the sale of its common stock in an IPO, plus another $118 million from a concurrent private placement, according to an amended registration statement . The company is advancing a number of drug development and gene therapy pro...

Introduction After I first published the article " The Coming Stock Market Crash - Smart Money Is Already Ringing The Death Bell " exclusively on my TEV blog and then here , it became my most read article ever on Seeking Alpha. In the article, I pointed out how massively the net assets in...